IN189741B - - Google Patents
Info
- Publication number
- IN189741B IN189741B IN3317DE1998A IN189741B IN 189741 B IN189741 B IN 189741B IN 3317DE1998 A IN3317DE1998 A IN 3317DE1998A IN 189741 B IN189741 B IN 189741B
- Authority
- IN
- India
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3317DE1998 IN189741B (es) | 1998-11-09 | 1998-11-09 | |
US09/268,554 US6093830A (en) | 1998-11-09 | 1999-03-15 | Enantioselective resolution process for arylpropionic acid drugs from the racemic mixture |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3317DE1998 IN189741B (es) | 1998-11-09 | 1998-11-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN189741B true IN189741B (es) | 2003-04-19 |
Family
ID=11092800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3317DE1998 IN189741B (es) | 1998-11-09 | 1998-11-09 |
Country Status (2)
Country | Link |
---|---|
US (1) | US6093830A (es) |
IN (1) | IN189741B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5702201A (en) * | 2000-04-13 | 2001-10-30 | Mayo Foundation | Abeta<sub>42</sub> lowering agents |
US20030027867A1 (en) * | 2001-06-29 | 2003-02-06 | Myriad Genetics, Incorporated | Use of R-NSAID compounds for anti-HIV treatment |
WO2004071431A2 (en) * | 2003-02-05 | 2004-08-26 | Myriad Genetics, Inc. | Method and composition for treating neurodegenerative disorders |
US7199259B2 (en) * | 2003-06-20 | 2007-04-03 | Metabolex, Inc. | Resolution of α-(phenoxy)phenylacetic acid derivatives |
AU2004311577A1 (en) * | 2003-07-11 | 2005-07-21 | Myriad Genetics, Inc. | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease |
WO2006001877A2 (en) * | 2004-04-13 | 2006-01-05 | Myriad Genetics, Inc. | Combination treatment for neurodegenerative disorders comprising r-flurbiprofen |
US20050252144A1 (en) * | 2004-04-29 | 2005-11-17 | Macdonald Robert A | Veneers for walls, retaining walls and the like |
WO2006020852A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
BRPI0514303A (pt) * | 2004-08-11 | 2008-06-10 | Myriad Genetics Inc | composição farmacêutica e método para tratar distúrbios neurodegenerativos |
WO2006020850A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
CN101146764A (zh) * | 2005-01-25 | 2008-03-19 | 冬姆佩制药股份公司 | 2-芳基丙酸衍生物的代谢产物及包含它们的药物组合物 |
CA2615063A1 (en) * | 2005-07-22 | 2007-02-01 | Myriad Genetics, Inc. | High drug load formulations and dosage forms |
US7714131B2 (en) * | 2005-09-23 | 2010-05-11 | Metabolex, Inc. | Process for the stereoselective preparation of (−)-halofenate and derivatives thereof |
US20080033045A1 (en) * | 2006-07-07 | 2008-02-07 | Myriad Genetics, Incorporated | Treatment of psychiatric disorders |
WO2008058235A2 (en) * | 2006-11-08 | 2008-05-15 | Dr. Reddy's Laboratories, Ltd. | Processes for the preparation of cinacalcet |
CN113929590B (zh) * | 2021-11-03 | 2023-09-05 | 上海工程技术大学 | 一种非均相成核结晶法拆分手性天冬氨酸的方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4209638A (en) * | 1977-03-08 | 1980-06-24 | The Boots Company Limited | Preparation of therapeutic agents |
US4246193A (en) * | 1979-11-26 | 1981-01-20 | Syntex Corporation | Process for the resolution of d,1 2-(6-methoxy-2-naphthyl)propionic acid |
CH641432A5 (de) * | 1978-07-19 | 1984-02-29 | Syntex Pharma Int | Verfahren zur aufspaltung von racemischer 6-methoxy-alpha-methyl-2-naphthalinessigsaeure in die optischen antipoden. |
US4515811A (en) * | 1979-07-06 | 1985-05-07 | Syntex Corporation | Process for the resolution of d,1 2-(6-methoxy-2-naphthyl)propionic acid |
ZA828453B (en) * | 1981-12-08 | 1983-12-28 | Boots Co Plc | Therapeutic agents |
DE3824353A1 (de) * | 1988-07-19 | 1990-01-25 | Paz Arzneimittelentwicklung | Verfahren zur trennung von gemischen enantiomerer arylpropionsaeuren |
US4994604A (en) * | 1990-01-10 | 1991-02-19 | Merck & Co., Inc. | Formation and resolution of ibuprofen lysinate |
US5015764A (en) * | 1990-06-18 | 1991-05-14 | Ethyl Corporation | Preparation of optically active aliphatic carboxylic acids |
US5189208A (en) * | 1991-07-01 | 1993-02-23 | Ethyl Corporation | Ibuprofen resolution |
US5332834A (en) * | 1992-12-02 | 1994-07-26 | Hoechst Celanese Corporation | Racemization of an enantomerically enriched α-aryl carboxylic acid |
ATE151740T1 (de) * | 1992-12-02 | 1997-05-15 | Knoll Ag | Verfahren zur herstellung von im wesentlichen enantiomeren der phenylpropionsäuren |
JPH08151344A (ja) * | 1994-09-26 | 1996-06-11 | Nagase & Co Ltd | 2−(3−ベンゾイルフェニル)プロピオン酸の光学分割方法 |
US5621140A (en) * | 1994-12-22 | 1997-04-15 | Syntex (U.S.A.) Inc. | Resolution of ibuprofen |
-
1998
- 1998-11-09 IN IN3317DE1998 patent/IN189741B/en unknown
-
1999
- 1999-03-15 US US09/268,554 patent/US6093830A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6093830A (en) | 2000-07-25 |